Literature DB >> 32258728

A posttranslational modification in histones as prognostic/predictive marker in Estrogen-Positive Breast Cancer: PS209.

S Lobo1,2, M Fontes-Sousa2,3, S Salta2, P Lopes2,4, J Lobo2,4, S Sousa3, R Henrique2,4,5, C Jerónimo2,5.   

Abstract

Entities:  

Year:  2017        PMID： 32258728      PMCID： PMC6806880          DOI： 10.1016/j.pbj.2017.07.116

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN： 2444-8664


× No keyword cloud information.
  4 in total

1.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Senkus; S Kyriakides; S Ohno; F Penault-Llorca; P Poortmans; E Rutgers; S Zackrisson; F Cardoso
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

Review 2.  Aberrations of EZH2 in cancer.

Authors:  Andrew Chase; Nicholas C P Cross
Journal:  Clin Cancer Res       Date:  2011-03-02       Impact factor: 12.531

Review 3.  EZH2 methyltransferase and H3K27 methylation in breast cancer.

Authors:  Kyung Hyun Yoo; Lothar Hennighausen
Journal:  Int J Biol Sci       Date:  2011-11-18       Impact factor: 6.580

4.  Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior.

Authors:  Akimasa Hayashi; Naoko Yamauchi; Junji Shibahara; Hiroshi Kimura; Teppei Morikawa; Shumpei Ishikawa; Genta Nagae; Akihiro Nishi; Yoshihiro Sakamoto; Norihiro Kokudo; Hiroyuki Aburatani; Masashi Fukayama
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.